Liver Disease Clinical Trials in Los Angeles, California
13 recruitingLos Angeles, California
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled561 locationsNCT07165028
Recruiting
Primary Sclerosing Cholangitis in Children
Liver DiseasesPrimary Sclerosing CholangitisCholangitis, Sclerosing
Arbor Research Collaborative for Health1,000 enrolled12 locationsNCT04181138
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.1,350 enrolled349 locationsNCT06318169
Recruiting
Phase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,200 enrolled49 locationsNCT07221227
Recruiting
Phase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,250 enrolled43 locationsNCT07221188
Recruiting
Phase 1Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Healthy VolunteersMetabolic dysfunction–associated steatotic liver disease (MASLD)
Regeneron Pharmaceuticals172 enrolled6 locationsNCT05648214
Recruiting
DILIN - Prospective Study
Liver Diseases
Duke University4,000 enrolled6 locationsNCT00345930
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Liver Diseases, Alcoholic
GlaxoSmithKline393 enrolled131 locationsNCT06613698
Recruiting
Phase 1Phase 2
Immune Tolerance Induction After Liver Transplantation
Liver TransplantationEnd Stage Liver DiseaseImmune Tolerance+6 more
University of California, Los Angeles12 enrolled1 locationNCT07269041
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Liver Transplant; ComplicationsLiver CirrhosisLiver Diseases+1 more
European Foundation for Study of Chronic Liver Failure3,000 enrolled106 locationsNCT04613921
Recruiting
Genetic Collection Protocol
Liver Diseases
Arbor Research Collaborative for Health2,230 enrolled13 locationsNCT05272319
Recruiting
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Pediatric ALLMalnutritionParenteral Nutrition Associated Liver Disease (PNALD)+1 more
Fresenius Kabi40 enrolled10 locationsNCT06274788
Recruiting
Not Applicable
CM for Patients With ALD After Liver Transplant
Alcohol Use DisorderContingency ManagementAlcohol Liver Disease+2 more
Arpan A. Patel, MD30 enrolled1 locationNCT06304467